Background Community transmission of coronavirus 2019 (Covid-19) was detected in the
state of Washington in February 2020. Methods We identified patients from nine Seattle-area …

Diagnostic testing has played and will continue to play a major role in the coronavirus
disease 2019 (COVID-19) pandemic. The ability to detect severe acute respiratory syndrome …

Introduction: Diagnostic metagenomics and its associated trail of publications are spreading
across the world. Multiple clinical labs in the United States, Europe, and Asia have gone to …

Background NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine
that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (…

Detection of SARS-CoV-2 with a CRISPR-Based Test A new method for the detection of
SARS-CoV-2 combines simplified extraction of RNA with isothermal amplification and CRISPR (…

Nearly 400,000 people worldwide are known to have been infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) beginning in December 2019. The virus has …

The development of vaccines against SARS-CoV-2 would be greatly facilitated by the
identification of immunological correlates of protection in humans. However, to date, studies on …

Coronavirus disease 2019 (COVID-19), the novel respiratory illness caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with severe morbidity and …

Although infections among vaccinated individuals lead to milder COVID-19 symptoms
relative to those in unvaccinated subjects, the specificity and durability of antibody responses …

We report unbiased metagenomic detection of chikungunya virus (CHIKV), Ebola virus (EBOV),
and hepatitis C virus (HCV) from four human blood samples by MinION nanopore …